A group of scientists convened by the National Cancer Institute and chaired by a UCSF breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”
Latest News
May 28, 2013
WHAT: The UC San Francisco Department of Dermatology is offering free skin cancer screenings. No appointment is necessary and no insurance is required.
WHEN: Saturday, June 1, 8 a.m. to 4 p.m. The screenings will take approximately 30 minutes.
WHERE: Castro Mission Health Center
3850 17th Street at Noe Street
San Francisco, CA 94114
April 29, 2013
Surgery is often recommended for skin cancers, but older, sicker patients can endure complications as a result and may not live long enough to benefit from the treatment.
January 07, 2013
The National Cancer Institute has awarded the UCSF Helen Diller Family Comprehensive Cancer Center a $36 million support grant that will fund infrastructure for clinical trials, cutting-edge research and programmatic support over five years.
January 04, 2013
A team of UCSF researchers have conducted the most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness.
December 13, 2012
St. Joseph’s Medical Center is bringing advanced cancer care to San Joaquin County with a new collaboration between St. Joseph’s Regional Cancer Center and the UCSF Helen Diller Family Comprehensive Cancer Center that will enhance patient care and access to clinical trials.
December 04, 2012
The Regional Cancer Center at ValleyCare and UCSF Helen Diller Family Comprehensive Cancer Center have joined forces to enhance patient care and improve access to top level medical experts.
August 07, 2012
Marin County, Calif., has one of the highest rates of breast cancer in the world, a fact that scientists know has nothing to do with the land itself but with some other, unknown factor.
July 10, 2012
Cancer patients across the country have a new way to navigate through difficult treatment decisions and communicate better with their doctors. “Open to Options,’’ which recently launched nationally, was developed in conjunction with UCSF to guide patients in making critical health decisions.
July 01, 2012
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.
